Innovating Works

FUNDACIÓN DR. CARLOS ELÓSEGUI DE POLICLÍNICA DE GUIPUZCOA

Activa
AIMS-2-TRIALS: Autism Innovative Medicine Studies – 2 – Trials KINGS COLLEGE LONDON tramitó un H2020: Autism Spectrum Disorder (ASD) is a heterogeneous neurodevelopmental condition affecting over five million people in the European Union. The combination of core symptoms (deficits in social-communica...
2018-06-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.